China biotech bags a $57M round as it races to complete R&D, manufacturing site
A group of marquee investors with close ties to Just Biotherapeutics in Seattle have come together to back a $57 million round for a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
